Skip to main content
. 2017 Jun 8;12(6):e0178685. doi: 10.1371/journal.pone.0178685

Table 2. SNPs allele distribution in HIV positive patients, HIV positive patients with fatty liver, healthy controls and alcoholic fatty liver.

Healthy controls (n = 149) HIV patients (all) (n = 117) HIV patients with fatty liver (n = 13) HIV patients with probable fatty liver (n = 65) HIV patients without fatty liver (n = 39) Patients with alcoholic fatty liver (n = 133)
PNPLA3 (rs738409)
CC 89 (59.7%) 75 (64.1%) 10 (76.9%) 38 (58.5%) 27 (69.2%) 52 (39.1%)
GC 53 (35.6%) 37 (31.6%) 2 (15.4%) 25 (38.5%) 10 (25.6%) 64 (48.1%)
GG 7 (4.7%) 5 (4.3%) 1 (7.7%) 2 (3.1%) 2 (5.1%) 17 (12.8%) A)
CSPG3/NCAN (rs2228603)
CC 124 (83.2%) 104 (88.9%) 11 (84.6%) 57 (87.7%) 36 (92.3%) 107 (80.4%)
CT 23 (15.4%) 12 (10.3%) 2 (15.4%) 8 (12.3%) 2 (5.1%) 23 (17.3%)
TT 2 (1.3%) 1 (0.9%) 0 (0%) 0 (0%) 1 (2.6%) 3 (2.3%)
GCKR (rs780094)
GG 53 (35.6%) 41 (35.0%) 3 (23.1%) 18 (27.7%) 20 (51.3%) 49 (36.8%)
GA 77 (51.7%) 60 (51.3%) 10 (76.9%) 34 (52.3%) 16 (41.0%) 64 (48.1%)
AA 19 (12.8%) 16 (13.7%) 0 (0%) 13 (20.0%) 3 (7.7%) 20 (15.0%)
PPP1R3B (rs4240624)
AA 124 (83.2%) 96 (82.1%) 12 (92.3%) 50 (76.9%) 34 (87.2%) 112 (84.2%)
AG 25 (16.8%) 21 (17.9%) 1 (7.7%) 15 (23.1%) 5 (12.8%) 20 (15.0%)
GG 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (0.8%)
LYPLAL (rs12137855)
CC 107 (71.8%) 72 (61.5%) 8 (61.5%) 39 (60.0%) 25 (64.1%) 90 (67.7%)
CT 38 (25.5%) 40 (34.2%) 5 (38.5%) 22 (33.8%) 13 (33.3%) 40 (30.1%)
TT 4 (2.7%) 5 (4.3%) 0 (0%) 4 (6.2%) 1 (2.6%) 3 (2.3%)
TM6FS2 (rs8542926)
CC 125 (83.9%) 103 (88.0%) 11 (84.6%) 56 (86.2%) 36 (92.3%) 105 (78.9%)
CT 22 (14.8%) 13 (11.1%) 2 (15.4%) 9 (13.8%) 2 (5.1%) 23 (17.3%)
TT 2 (1.3%) 1 (0.9%) 0 (0%) 0 (0%) 1 (2.6%) 5 (3.8%)
MBOAT (rs626283)
CC nd 38 (32.5%) 3 (23.1%) 19 (29.2%) 16 (41.0%) Nd
CT nd 57 (48.7%) 6 (46.2%) 35 (52.3%) 17 (43.6%) Nd
TT nd 22 (18.8%) 4 (30.8%) 12 (18.5%) 6 (15.4%) Nd

A) Patients with alcoholic fatty liver vs. healthy controls p = 0.00018